• No results found

[PDF] Top 20 Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis

Has 10000 "Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis" found on our website. Below are the top 20 most common "Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis".

Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis

Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis

... Other reports have provided supporting evidence for a role of Neu1 in the receptor glycosylation modification model in respiratory airway epithelia. Lillehoj et al. [49] have demonstrated that Neu1 associates with EGFR ... See full document

22

miRNA-21 as a novel therapeutic target in lung cancer

miRNA-21 as a novel therapeutic target in lung cancer

... open novel fields in biomarker research, in diagnosis, and in ...involved 1) as a biomarker in response or resistance to therapy or 2) as a therapeutic ... See full document

9

NFATC2 is a novel therapeutic target for colorectal cancer stem cells

NFATC2 is a novel therapeutic target for colorectal cancer stem cells

... Figure 3 Knockdown of nFaTc2 inhibits the stemness of crc cells. (A, B) sphere formation assay of nFaTc2-knockdown and control primary crc cells. Primary crc cells were isolated from the cancer tissues of crc patients ... See full document

14

The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma

The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma

... ATPase activity with V0 rotation [1]. Multiple roles have been attributed to V-ATPase in physiological conditions, among which regulation of pH balance, control of neurotransmitter trafficking and degradation of ... See full document

18

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

... Abstract: In the last decade, cancer research efforts in the field of noncoding microRNA (miRNA) have been growing exponentially. miRNA-based therapeutics have been tested in both preclinical and clinical settings, and ... See full document

5

RPS2: a novel therapeutic target in prostate cancer

RPS2: a novel therapeutic target in prostate cancer

... Although our understanding of their role in cancer is lim- ited, the expression of a variety of ribosomal proteins has been associated with the development of prostate and colon cancer. For example, we have previously ... See full document

12

Cripto-1 as a novel therapeutic target for triple negative breast cancer

Cripto-1 as a novel therapeutic target for triple negative breast cancer

... Since CRIPTO-1 physically interacts with all four Notch receptors and Notch4 and Cripto-1 has been shown to be relevant in embryogenesis, maintenance of a human BC stem cell population and ... See full document

20

MAGE D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis

MAGE D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis

... D4B is a valuable candidate as a novel biomarker in breast cancer. MAGE family genes were initially identified as genes encoding tumor-specific antigens, and since then MAGE type I genes have been extensively ... See full document

12

MERTK as a novel therapeutic target in head and neck cancer

MERTK as a novel therapeutic target in head and neck cancer

... potential therapeutic target by in-vitro overexpression, inhibition and knockdown ...predict therapeutic success since the small molecule inhibitors target the protein itself ... See full document

17

Nuclear Localization Signal of HIV-1 as a Novel Target for Therapeutic Intervention

Nuclear Localization Signal of HIV-1 as a Novel Target for Therapeutic Intervention

... (1992) Active nuclear import of human immunodeficiency virus type 1 preintegra- tion complex. Stevenson M, Bukrinsky M, Haggerty S[r] ... See full document

14

The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus induced cardiac injury

The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus induced cardiac injury

... Inhibition of antiviral effect of cytokines by SOCS in cultured myocytes. Given the importance of JAK-STAT signaling in the SOCS1 transgenic mice, we sought to determine whether cytokines that activate JAK- STAT ... See full document

11

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

... none; 1, <10%; 2, 10–50%; and 3, >50% of all cancer ...staining; 1, weak staining; 2, moderate staining; and 3, strong ...0, 1, 2, 3, 4, 6, and ... See full document

11

AMPD1: a novel therapeutic target for reversing insulin resistance

AMPD1: a novel therapeutic target for reversing insulin resistance

... Given that skeletal muscle is one of the major organs that contributes to insulin resistance it stands to reason that therapies directed to targets expressed in this tissue may offer novel approaches to treating ... See full document

7

AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders

AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders

... potential therapeutic target is Abelson helper integration site-1(Ahi-1/AHI-1) that was identified by retroviral insertional mutagenesis in murine models of leukemia/lymphomas and is ... See full document

17

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

... with vehicle or 11a-1, stained cell nucleus with Hoechst and monitored the mean moving distance of cells by an ArrayScan high-content screening system. As shown in Figure 4C, 11a-1 treatment ... See full document

13

Acid ceramidase is upregulated in AML and represents a novel therapeutic target

Acid ceramidase is upregulated in AML and represents a novel therapeutic target

... to 1 mg of protein depending on the experiment) using an azeotrophic mix of isopropanol:water:ethyl acetate (3:1:6; ...and 1-phosphates or a Supelco ... See full document

15

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies

... HDACi are a novel class of structurally diverse natural and synthetic compounds that modulate a myriad of cellular functions by inhibiting HDAC activity. The ability of various HDACis such as LBH589 (Panobinostat, ... See full document

16

The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine

... cytes [1], but have also been found in several tissues, in- cluding pancreatic α- and ß-cells, smooth muscle, skeletal muscle and central neurons [2, 3]. The channels belong to the family of inwardly rectifying K ... See full document

9

High-density lipoproteins: a novel therapeutic target for cardiovascular disease

High-density lipoproteins: a novel therapeutic target for cardiovascular disease

... available therapeutic and lifestyle strategies, when optimized, increase HDL levels by ...Some novel therapeutic agents in human studies appear to increase HDL levels effectively, whereas other ... See full document

6

Serum High Mobility Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections

Serum High Mobility Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections

... IMPORTANCE Influenza virus is a common infectious agent causing serious sea- sonal epidemics, and there is urgent need to develop an alternative treatment modality for influenza virus infection. Recently, host-derived ... See full document

13

Show all 10000 documents...